Our study shows for the first time that early intervention using the ITK inhibitor strategy may limit sepsis-induced neuroinflammation and depression via the regulation of the Th17/Treg balance, which may improve the long-term survival and better the prognosis of septic patients. This evidence concerns the gene ITK and depressive symptom measurement.